Champ 2.0

Important Information

AMP 2012 Annual Meeting on Genomic Medicine
October 25 - 27, 2012
Long Beach Convention & Entertainment Center
Long Beach, CA
Visit Meeting Page

AMP MGP Online Self-Study Review Course
Available September 1, 2011 - December 31, 2012
Visit the Course Page

Special Features

AMP International
AMP Test Directory
Awards, Grants & Honors
Career Development
Membership Information
Online Member Directory
The Journal of Molecular Diagnostics
Trainee Programs
Web Library

How to Help

Corporate Support Opportunities
Donate to AMP

Volunteer

AP RSS Feed Linked In FaceBook Twitter
More Information

Economic Affairs Committee


Jeffrey A. Kant MD, PhD. (Chair)
University of Pittsburgh Medical Center
Email

Committee Members

2011 Annual Committee Report

Committee/Subdivision Purpose and Responsibilities

AMP Position Statements and Letters

 

economic affairs committee

Economic Affairs Committee

Economic Affairs Committee

The purpose of the Economic Affairs Committee (EAC) is to address, advise, and educate the AMP Council, membership, payers, legislators, and the public on economic issues of importance to the field of molecular pathology, to prepare documents of importance to the Centers for Medicare & Medicaid Services (CMS), and to develop and advocate for sound economic polices that promote the provision of high quality molecular pathology services.  The Committee's scope encompasses short and long-term issues associated with utilization of and coverage for billing codes used in molecular pathology, to the potential economic impact of public policy decisions on molecular pathology practice.  The Committee will interact with the American Medical Association and other interested organizations in order to achieve our common goals.

EAC Updates

March 10, 2011: AMA CPT Panel released the outline of a new coding system for molecular pathology assays in genetics, oncology and histocompatibility.  The system is based on the EAC White Paper: Proposal for CPT Coding Reform for Molecular Diagnostics.